Academic Journal

Inhibition of cholesterol biosynthesis by squalene epoxidase inhibitor avoids apoptotic cell death in L6 myoblasts

التفاصيل البيبلوغرافية
العنوان: Inhibition of cholesterol biosynthesis by squalene epoxidase inhibitor avoids apoptotic cell death in L6 myoblasts
المؤلفون: S Matzno, T Yamauchi, M Gohda, N Ishida, K Katsuura, Y Hanasaki, T Tokunaga, H Itoh, N Nakamura
المصدر: Journal of Lipid Research, Vol 38, Iss 8, Pp 1639-1648 (1997)
بيانات النشر: Elsevier, 1997.
سنة النشر: 1997
المجموعة: LCC:Biochemistry
مصطلحات موضوعية: Biochemistry, QD415-436
الوصف: The relationship between the inhibition of cholesterol biosynthesis and occurrence of myopathy was studied in L6 myoblasts using two lines of cholesterol biosynthesis inhibitors, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor (simvastatin) and squalene epoxidase inhibitors (TU-2078 and NB-598). All inhibitors completely inhibited the cholesterol synthesis in L6 myoblasts at doses of 1 and 3 microM. Simvastatin (3 microM) inhibited the fusion reaction of L6 myoblasts followed by the severe cellular damage. The myoblasts also had failed actin fiber formation and creatinine phosphokinase (CPK) production. Additionally, this agent also caused apoptotic cell death in differentiated L6 muscle fiber, indicating that skeletal myopathy by HMG-CoA reductase inhibitors seems to occur not only in differentiating immature myoblasts but also in matured skeletal myotubes. In contrast, TU-2078 and NB-598 had no effect on the fusion reaction of differentiating myoblasts or on the cellular viability of muscle fiber at 3 microM, enough to completely inhibit cholesterol biosynthesis. It is conceivable that the mevalonate depletion and subsequent failure of ras farnesylation induced by simvastatin might cause the defects in differentiation and maintenance of the muscle fiber. Squalene epoxidase inhibitors did not show this adverse effect presumably because of the enzyme inhibition downstream of farnesyl synthesis. The present findings suggest the safe use of squalene epoxidase inhibitors in lipid-lowering therapy.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 0022-2275
Relation: http://www.sciencedirect.com/science/article/pii/S0022227520371820; https://doaj.org/toc/0022-2275
DOI: 10.1016/S0022-2275(20)37182-0
URL الوصول: https://doaj.org/article/6cc5d74f3122401d9ec4fb054580e92b
رقم الانضمام: edsdoj.6cc5d74f3122401d9ec4fb054580e92b
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:00222275
DOI:10.1016/S0022-2275(20)37182-0